Gut Microbes and a Key Metabolite Linked to Cognitive Attention in Obesity
A comprehensive study published in *Gut* reveals a novel gut-brain axis mechanism where obesity-related microbiota alterations influence attention. Researchers conducted multi-cohort analyses combining fecal metagenomics and plasma metabolomics, identifying the microbial tryptophan pathway and the metabolite 3-hydroxyanthranilic acid (3-HAA) as central players. Functional validation through fecal microbiota transplantation in mice and *Drosophila* models demonstrated that diet-induced obesity depletes prefrontal cortex levels of 3-HAA and related neurotransmitters, impairing attention. Critically, supplementing 3-HAA or transplanting microbiota from high-attention donors reversed these deficits, highlighting a direct microbial modulation of dopaminergic and serotonergic signaling that affects cognitive function.
Study Significance: For pulmonologists managing obesity-related conditions like obstructive sleep apnea and hypoxemia, this research expands the clinical picture beyond the respiratory system. It suggests that assessing gut microbiome composition and targeted metabolites like 3-HAA could provide insights into comorbid cognitive deficits, potentially guiding adjunctive therapeutic strategies. This work underscores the importance of a systems medicine approach in chronic respiratory diseases where metabolic and cognitive comorbidities significantly impact patient quality of life and outcomes.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
